d-Alanine Affects the Circadian Clock to Regulate Glucose Metabolism in Kidney.


Journal

Kidney360
ISSN: 2641-7650
Titre abrégé: Kidney360
Pays: United States
ID NLM: 101766381

Informations de publication

Date de publication:
15 Dec 2023
Historique:
received: 22 09 2023
accepted: 07 12 2023
medline: 15 12 2023
pubmed: 15 12 2023
entrez: 15 12 2023
Statut: aheadofprint

Résumé

The aberrant glucose circadian rhythm is associated with the pathogenesis of diabetes. Similar to glucose metabolism in kidney and liver, d-alanine, a rare enantiomer of alanine, shows circadian alteration, although the effect of d-alanine on glucose metabolism has not been explored. Here we show that d-alanine acts on the circadian clock and affects glucose metabolism in the kidney. The blood and urinary levels of d-alanine in mice were measured using two-dimensional high performance liquid chromatography system. Metabolic effects of d-alanine were analysed in mice and in primary culture of kidney proximal tubular cells from mice. Behavioural and gene expression analyses of circadian rhythm were performed using mice bred under constant darkness. d-Alanine levels in blood exhibited a clear intrinsic circadian rhythm. Since this rhythm was regulated by the kidney through urinary excretion, we examined the effect of d-alanine on kidney. In kidney, d-alanine induced expressions of genes involved in gluconeogenesis and circadian rhythm. Treatment of d-alanine mediated glucose production in mice. Ex vivo glucose production assay demonstrated that treatment of d-alanine induced glucose production in primary culture of kidney proximal tubular cells, where d-amino acids are known to be reabsorbed, but not in that of liver cells. Gluconeogenetic effect of d-alanine has an intraday variation, and this effect was in part mediated through circadian transcriptional network. Under constant darkness, treatment of d-alanine normalized the circadian cycle of behaviour and kidney gene expressions. d-Alanine induces gluconeogenesis in the kidney and adjusts the period of the circadian clock. Normalization of circadian cycle by d-alanine may provide the therapeutic options for life style-related diseases and shift workers.

Sections du résumé

BACKGROUND BACKGROUND
The aberrant glucose circadian rhythm is associated with the pathogenesis of diabetes. Similar to glucose metabolism in kidney and liver, d-alanine, a rare enantiomer of alanine, shows circadian alteration, although the effect of d-alanine on glucose metabolism has not been explored. Here we show that d-alanine acts on the circadian clock and affects glucose metabolism in the kidney.
METHODS METHODS
The blood and urinary levels of d-alanine in mice were measured using two-dimensional high performance liquid chromatography system. Metabolic effects of d-alanine were analysed in mice and in primary culture of kidney proximal tubular cells from mice. Behavioural and gene expression analyses of circadian rhythm were performed using mice bred under constant darkness.
RESULTS RESULTS
d-Alanine levels in blood exhibited a clear intrinsic circadian rhythm. Since this rhythm was regulated by the kidney through urinary excretion, we examined the effect of d-alanine on kidney. In kidney, d-alanine induced expressions of genes involved in gluconeogenesis and circadian rhythm. Treatment of d-alanine mediated glucose production in mice. Ex vivo glucose production assay demonstrated that treatment of d-alanine induced glucose production in primary culture of kidney proximal tubular cells, where d-amino acids are known to be reabsorbed, but not in that of liver cells. Gluconeogenetic effect of d-alanine has an intraday variation, and this effect was in part mediated through circadian transcriptional network. Under constant darkness, treatment of d-alanine normalized the circadian cycle of behaviour and kidney gene expressions.
CONCLUSIONS CONCLUSIONS
d-Alanine induces gluconeogenesis in the kidney and adjusts the period of the circadian clock. Normalization of circadian cycle by d-alanine may provide the therapeutic options for life style-related diseases and shift workers.

Identifiants

pubmed: 38098136
doi: 10.34067/KID.0000000000000345
pii: 02200512-990000000-00306
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology.

Auteurs

Shinsuke Sakai (S)

Department of Nephrology, Osaka University Graduate School of Medicine.
Reverse Translational Project, National Institutes of Biomedical Innovation, Health and Nutrition.
KAGAMI Project, National Institutes of Biomedical Innovation, Health and Nutrition.

Youichi Tanaka (Y)

Department of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University.

Yusuke Tsukamoto (Y)

Reverse Translational Project, National Institutes of Biomedical Innovation, Health and Nutrition.
KAGAMI Project, National Institutes of Biomedical Innovation, Health and Nutrition.

Shihoko Kimura-Ohba (S)

Reverse Translational Project, National Institutes of Biomedical Innovation, Health and Nutrition.
KAGAMI Project, National Institutes of Biomedical Innovation, Health and Nutrition.

Atsushi Hesaka (A)

Department of Nephrology, Osaka University Graduate School of Medicine.
Reverse Translational Project, National Institutes of Biomedical Innovation, Health and Nutrition.
KAGAMI Project, National Institutes of Biomedical Innovation, Health and Nutrition.

Kenji Hamase (K)

Reverse Translational Project, National Institutes of Biomedical Innovation, Health and Nutrition.
Graduate School of Pharmaceutical Sciences, Kyushu University.

Chin-Ling Hsieh (CL)

Graduate School of Pharmaceutical Sciences, Kyushu University.

Eiryo Kawakami (E)

Reverse Translational Project, National Institutes of Biomedical Innovation, Health and Nutrition.
Department of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University.
Advanced Data Science (ADSP), RIKEN Information R&D and Strategy Headquarters.
Institute for Advanced Academic Research (IAAR), Chiba University.

Hiraku Ono (H)

Department of Endocrinology, Hematology and Gerontorogy, Graduate School of Medicine, Chiba University.

Kotaro Yokote (K)

Department of Endocrinology, Hematology and Gerontorogy, Graduate School of Medicine, Chiba University.

Mitsuaki Yoshino (M)

Laboratory of Rare Disease Information and Resource library, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN).

Daisuke Okuzaki (D)

Genome Information Research Center, Research Institute for Microbial Disease, Osaka University.

Hiroyo Matsumura (H)

Reverse Translational Project, National Institutes of Biomedical Innovation, Health and Nutrition.
KAGAMI Project, National Institutes of Biomedical Innovation, Health and Nutrition.

Atsuko Fukushima (A)

Reverse Translational Project, National Institutes of Biomedical Innovation, Health and Nutrition.
KAGAMI Project, National Institutes of Biomedical Innovation, Health and Nutrition.

Masashi Mita (M)

KAGAMI Inc.

Maiko Nakane (M)

KAGAMI Inc.

Masao Doi (M)

Department of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University.

Yoshitaka Isaka (Y)

Department of Nephrology, Osaka University Graduate School of Medicine.

Tomonori Kimura (T)

Department of Nephrology, Osaka University Graduate School of Medicine.
Reverse Translational Project, National Institutes of Biomedical Innovation, Health and Nutrition.
KAGAMI Project, National Institutes of Biomedical Innovation, Health and Nutrition.

Classifications MeSH